Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19. Gottlieb RL, Paredes R. Lancet Infect Dis 2023 Nov 22:S1473-3099(23)00633.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gottlieb RL, Paredes R. Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19. Lancet Infect Dis 2023 Nov 22:S1473-3099(23)00633.
PMID: 38006893